Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Robichaud, AL"'
Publikováno v:
In Value in Health June 2024 27(6) Supplement:S191-S191
Autor:
Guenther LM, Dharia NV, Ross L, Saur Conway A, Robichaud AL, Catlett JL, Wechsler C, Frank ES, Goodale AB, Church AJ, Tseng YY, Guha R, McKnight C, Janeway KA, Boehm JS, Mora J, Davis MI, Alexe G, Piccioni F, Stegmaier K
Publikováno v:
CLINICAL CANCER RESEARCH
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
PURPOSE: Novel targeted therapeutics have transformed the care of subsets of patients with cancer. In pediatric malignancies, however, with simple tumor genomes and infrequent targetable mutations, there have been few new FDA-approved targeted drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0e89c0c7bf876fd4c61c36ffab070477
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15250
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=15250
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Comery, Thomas A. 1, Aschmies, Suzan 1, Haydar, Simon 1, Hughes, Zoe 1, Huselton, Christine 2, Kowal, Dianne 1, Kramer, Angela 1, McFarlane, Geraldine 1, Monaghan, Michael 1, Smith, Deborah 1, Zhang, Guoming 1, Zhang, Jean 1, Zhang, Mei-Yi 1, Reinhart, Peter 1, Robichaud, Al J. 1, Pangalos, Menelas N. 1
Publikováno v:
In Alzheimer's & Dementia: The Journal of the Alzheimer's Association July 2010 6(4) Supplement:S548-S549
Autor:
Robichaud, Alain
Cette thèse porte sur l’étude des fondements de l’action de dirigeants de grandes entreprises au Québec. Ces dirigeants ont en commun d’avoir assumé cette fonction pendant plus de vingt ans, d’être tous très reconnus par la commun
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paolino J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Dimitrov B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Apsel Winger B; Department of Pediatrics, Division of Hematology/Oncology, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Sandoval-Perez A; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Rangarajan AV; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Ocasio-Martinez N; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai HK; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Li Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hatton C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Polonen P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Dilig A; Integrated Oncology, Shelton, Connecticut., Gotti G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Kavanagh J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adhav AA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gow S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bledsoe J; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, and Department of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Cooper SL; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland., Cooper TM; Seattle Children's Hospital, Cancer and Blood Disorders Center, Seattle, Washington., Hijiya N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York., Sulis ML; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Magee JA; Division of Pediatric Hematology/Oncology, Washington University/St. Louis Children's Hospital, St. Louis, Missouri., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Burke MJ; Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, Wisconsin., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mar BG; Blueprint Medicines, Cambridge, Massachusetts., Jacobson MP; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Harris MH; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4613-4626.
Autor:
Mabe NW; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Huang M; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Dalton GN; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Alexe G; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Schaefer DA; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Geraghty AC; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Conway AS; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA., Mader MM; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Belk JA; Department of Computer Science, Stanford University School of Medicine, Stanford, CA, USA., Ross KN; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Sheffer M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Linde MH; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA.; Immunology Graduate Program, Stanford University School of Medicine, Stanford, CA, USA., Ly N; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Yao W; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Rotiroti MC; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA., Smith BAH; Department of Chemical & Systems Biology, Stanford University School of Medicine, Stanford, CA, USA., Wernig M; Institute for Stem Cell Biology and Regenerative Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA., Bertozzi CR; Department of Chemistry, Stanford University School of Medicine, Stanford, CA, USA.; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA., Monje M; Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.; Howard Hughes Medical Institute, Stanford University, Stanford, CA, USA., Mitsiades CS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Majeti R; Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA, USA., Satpathy AT; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute and Boston Children's Hospital, Boston, MA, USA. Kimberly_stegmaier@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Kimberly_stegmaier@dfci.harvard.edu., Majzner RG; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. rmajzner@stanford.edu.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. rmajzner@stanford.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. rmajzner@stanford.edu.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Aug; Vol. 3 (8), pp. 976-993. Date of Electronic Publication: 2022 Jul 11.